Star Imaging and Path Lab Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN L85110DL2004PLC126679 Incorporated 31 May 2004 ROC Delhi HQ New Delhi, Delhi, India
Active Listed - BSE: 544482 Public Limited Company healthcare MSME · Medium
Market Cap
₹102 Cr
STARIMAGIN · BSE
Share Price
₹58.00
-0.89% today
Revenue
₹88.53 Cr
FY 2025-26 · +6.0% YoY
EBITDA
₹33.17 Cr
Margin 37.5%
Net Profit
₹19.29 Cr
FY 2025-26 · +21.0% YoY
P/E (TTM)
5.7x
P/B 1.0x
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹17.42 Cr
Issued & subscribed

About Star Imaging and Path Lab Limited

Data last updated:

Star Imaging and Path Lab Limited is a public limited company based in New Delhi, Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 31 May 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L85110DL2004PLC126679. The company has 2 GST registrations on record, none of which is active. It is a listed company as per MCA records. Its shares are listed on BSE: 544482.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹17.42 Cr. It is led by directors including Pawan Gupta (Managing Director) and Neelam Ratra.

Its last annual general meeting (AGM) was held on 24 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 4B/4 Tilak Nagar Near Sant Pura, New Delhi, Delhi, India – 110018.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹88.53 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹19.29 Cr (net margin 21.8%) and EBITDA of ₹33.17 Cr (EBITDA margin 37.5%). The net worth stands at ₹116.1 Cr (up 146.2% YoY). Total assets are valued at ₹137.66 Cr (up 70.4% YoY).

The company has about 13 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹24.1 Cr and satisfied charges of ₹38.68 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 1 case is pending. The company has 9 deals on record (3 secondary share transfers, 3 market trades, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in June 2026. Its 3 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 1 larger and 2 smaller; the largest is Atulaya Healthcare Private Limited with revenue of ₹85.65 Cr.

Star Imaging and Path Lab Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0003085). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website starimaging.in.

Company details

CIN L85110DL2004PLC126679
Registration Number 126679
Incorporation Date 31 May 2004
ROC Delhi
Listing Status Listed - Listed on BSE (544482)
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-11-0003085

CIN history

Star Imaging and Path Lab has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85110DL2004PLC126679, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L85110DL2004PLC126679Current
U85110DL2004PLC126679Previous
U85110DL2004PTC126679Previous

Recognitions & Rankings of Star Imaging and Path Lab

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-DL-11-0003085

Contact details

Star Imaging and Path Lab Limited's registered office is in New Delhi, Delhi.

  • Social Media
  • Registered Address
    4B/4 Tilak Nagar Near Sant Pura, New Delhi, Delhi, India – 110018
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs
Comprehensive company report
Star Imaging and Path Lab Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Star Imaging and Path Lab is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Star Imaging and Path Lab Limited, buy the company report.

Financials of Star Imaging and Path Lab Limited

FY 2025-26 filings available

Star Imaging and Path Lab Limited reported revenue of ₹88.53 Cr (up 6% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹88.53 Cr
+6.0% YoY
EBITDA
₹33.17 Cr
+13.1% YoY
Profit After Tax
₹19.29 Cr
+21.0% YoY
Net Worth
₹116 Cr
+146.2% YoY
Total Assets
₹138 Cr
+70.4% YoY
Total Debt
₹20.67 Cr
-36.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue88.5383.5078.7858.5369.09
Revenue growth+6.0%+6.0%+34.6%-15.3%-
EBITDA33.1729.3423.196.0514.70
EBITDA margin+37.5%+35.1%+29.4%+10.3%+21.3%
Profit before tax26.2721.4416.120.899.40
Net profit19.2915.9411.660.586.30
Net profit margin+21.8%+19.1%+14.8%+1.0%+9.1%
EPS (₹)11.0511.8082.783.8641.94
Balance sheet
Total assets13880.7962.8346.3248.62
Net worth11647.1531.3518.9318.36
Total debt20.6732.7430.6326.5629.57
Cash & bank51.615.3515.712.359.05
Net working capital10050.9435.5112.4023.19
Cash flow
Cash from operations23.34(2.63)18.345.2714.40
Cash from investing(12.75)(7.36)(6.87)(7.22)(4.14)
Cash from financing35.67(0.37)1.89(4.74)(6.98)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue88.5383.2478.5058.3768.94
Revenue growth+6.4%+6.0%+34.5%-15.3%-
EBITDA33.2328.5622.526.0214.68
EBITDA margin+37.5%+34.3%+28.7%+10.3%+21.3%
Profit before tax26.3321.3416.010.879.41
Net profit19.3315.9211.590.576.31
Net profit margin+21.8%+19.1%+14.8%+1.0%+9.2%
EPS (₹)11.0911.7982.253.8242.01
Balance sheet
Total assets13880.6262.7046.3048.56
Net worth11647.0631.2718.9318.36
Total debt20.6732.7430.6326.5629.52
Cash & bank51.515.1415.442.188.97
Net working capital10050.7535.3712.3923.12
Cash flow
Cash from operations23.44(2.49)18.256.4714.39
Cash from investing(12.75)(7.44)(6.87)(8.57)(4.14)
Cash from financing35.67(0.37)1.89(4.70)(6.99)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 19 Nov 2026
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue88.5383.5078.7858.5369.09
Revenue growth+6.0%+6.0%+34.6%-15.3%-
Other income1.000.291.190.150.18
Total expenses55.3654.1655.5952.4854.39
Employee cost0.007.497.248.318.90
EBITDA33.1729.3423.196.0514.70
EBITDA margin+37.5%+35.1%+29.4%+10.3%+21.3%
Depreciation5.934.965.243.343.53
Interest1.973.233.021.971.95
Profit before tax26.2721.4416.120.899.40
Tax7.005.473.660.313.09
Net profit19.2915.9411.660.586.30
Net profit margin+21.8%+19.1%+14.8%+1.0%+9.1%
EPS (₹)11.0511.8082.783.8641.94
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital17.4213.501.501.501.50
Reserves & surplus98.6833.6529.8517.4316.86
Shareholders' funds (net worth)11647.1531.3518.9318.36
Minority interest0.050.080.050.010.01
Secured loans5.7013.6511.4110.7511.74
Unsecured loans14.9719.0919.2215.8117.83
Total debt20.6732.7430.6326.5629.57
Total liabilities13880.7962.8346.3248.62
Assets
Gross block78.7168.4764.3556.4149.11
Net block25.2220.9121.7019.0115.05
Capital work in progress0.000.000.000.000.00
Investments0.000.000.000.000.00
Inventories0.380.240.530.630.08
Sundry debtors49.9350.7632.6417.6116.16
Cash & bank balances51.615.3515.712.359.05
Loans & advances12.8810.894.395.566.30
Total current assets11567.2453.2726.1531.59
Total current liabilities14.6416.3017.7613.758.40
Net working capital10050.9435.5112.4023.19
Total assets13880.7962.8346.3248.62
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash5.3515.712.359.055.77
Net cash from operating activities23.34(2.63)18.345.2714.40
Net cash from investing activities(12.75)(7.36)(6.87)(7.22)(4.14)
Net cash from financing activities35.67(0.37)1.89(4.74)(6.98)
Net change in cash46.26(10.37)13.36(6.69)3.28
Closing cash51.615.3515.712.359.05
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+6.0%+6.0%+34.6%-15.3%-
EBITDA growth+13.1%+26.5%+283.3%-58.8%-
PBT growth+22.5%+33.0%+1711.2%-90.5%+9997.0%
Net income growth+21.0%+36.7%+1910.3%-90.8%-
Revenue CAGR (3Y)+14.8%+6.5%---
EBITDA CAGR (3Y)+76.3%+25.9%---
Profitability & leverage
Net income margin+21.8%+19.1%+15.8%+1.0%+9.1%
Return on capital employed-+34.4%+35.1%+6.0%+23.3%
Return on net worth-+40.7%+49.5%+3.1%+34.3%
Debt / equity-0.811.141.501.61
Long-term debt / equity-0.390.600.830.91
Interest cover7.2313.2516.8272.6917.46
Efficiency & per share
Fixed asset turnover-1.261.301.111.41
Inventory turnover-216.88135.83164.87863.63
Debtors turnover-2.003.143.474.28
EPS (₹)11.0511.8082.783.8641.94
Dividend per share (₹)0.000.000.000.000.00
Book value per share (₹)0.0034.93209.01126.23122.37
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue88.5383.2478.5058.3768.94
Revenue growth+6.4%+6.0%+34.5%-15.3%-
Other income1.000.291.190.150.18
Total expenses55.3054.6855.9852.3554.26
Employee cost0.007.497.248.318.90
EBITDA33.2328.5622.526.0214.68
EBITDA margin+37.5%+34.3%+28.7%+10.3%+21.3%
Depreciation5.934.965.243.343.51
Interest1.972.552.461.961.94
Profit before tax26.3321.3416.010.879.41
Tax7.005.423.660.303.09
Net profit19.3315.9211.590.576.31
Net profit margin+21.8%+19.1%+14.8%+1.0%+9.2%
EPS (₹)11.0911.7982.253.8242.01
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital17.4213.501.501.501.50
Reserves & surplus98.6233.5629.7717.4316.86
Shareholders' funds (net worth)11647.0631.2718.9318.36
Secured loans5.7013.6511.4110.7511.74
Unsecured loans14.9719.0919.2215.8117.78
Total debt20.6732.7430.6326.5629.52
Total liabilities13880.6262.7046.3048.56
Assets
Gross block78.6968.4664.3556.4149.11
Net block25.2220.9321.7219.0215.06
Capital work in progress0.000.000.000.000.00
Investments0.010.010.010.010.01
Inventories0.380.240.530.630.08
Sundry debtors49.8750.6932.5817.5816.16
Cash & bank balances51.515.1415.442.188.97
Loans & advances12.8810.894.395.566.30
Total current assets11566.9652.9425.9531.51
Total current liabilities14.6016.2117.5713.568.39
Net working capital10050.7535.3712.3923.12
Total assets13880.6262.7046.3048.56
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash5.1415.442.188.975.71
Net cash from operating activities23.44(2.49)18.256.4714.39
Net cash from investing activities(12.75)(7.44)(6.87)(8.57)(4.14)
Net cash from financing activities35.67(0.37)1.89(4.70)(6.99)
Net change in cash46.36(10.30)13.27(6.80)3.26
Closing cash51.515.1415.442.188.97
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+6.4%+6.0%+34.5%-15.3%-
EBITDA growth+16.4%+26.8%+274.1%-59.0%-
PBT growth+23.4%+33.3%+1740.2%-90.8%+9997.0%
Net income growth+21.4%+37.4%+1933.3%-91.0%-
Revenue CAGR (3Y)+14.9%+6.5%---
EBITDA CAGR (3Y)+76.7%+24.8%---
Profitability & leverage
Net income margin+21.8%+19.1%+15.7%+1.0%+9.2%
Return on capital employed-+33.3%+33.9%+6.0%+23.3%
Return on net worth-+40.6%+49.2%+3.1%+34.3%
Debt / equity-0.811.141.501.61
Long-term debt / equity-0.390.600.830.90
Interest cover7.2210.8114.2473.1317.37
Efficiency & per share
Fixed asset turnover-1.251.301.111.40
Inventory turnover-216.21135.34164.42861.75
Debtors turnover-2.003.133.464.27
EPS (₹)11.0911.7982.253.8242.01
Dividend per share (₹)0.000.000.000.000.00
Book value per share (₹)0.0034.86208.46126.21122.38

To see the full year-wise statements and ratios of Star Imaging and Path Lab Limited, buy the company report.

Board of directors of Star Imaging and Path Lab Limited

Star Imaging and Path Lab has 7 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pawan GuptaManaging Director31 May 200422 Years 5 MonthsCurrent
Neelam RatraDirector16 Jun 20251 Years 5 MonthsCurrent
Dikshant NagpalDirector30 Nov 20241 Years 11 MonthsCurrent
Vimal GuptaDirector01 Jul 20242 Years 4 MonthsCurrent
Yogesh Kumar VirmaniDirector01 Jul 20242 Years 4 MonthsCurrent
Sameer SoodDirector27 Sep 20242 Years 1 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Peer comparison

Star Imaging and Path Lab Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Star Imaging and Path Lab Limitedthis company₹88.53 Cr (FY 2026)₹19.29 Cr21.8%6.0%New Delhi, Delhi, India
Atulaya Healthcare Private Limited₹85.65 Cr (FY 2024)21.0%Chandigarh, India
Pulse Diagnostics Private Limited₹80.71 Cr (FY 2024)27.0%Kolkata, West Bengal, India
Sanghi Medical Centre Private Limited₹77.91 Cr (FY 2025)16.0%New Delhi, Delhi, India

To see the full peer comparison of Star Imaging and Path Lab Limited, buy the company report.

Charges & borrowings

Open charges
₹24.1 Cr
Satisfied charges
₹38.68 Cr
Breakdown by lending institutions
Others₹16.48 Cr
Hdfc Bank Limited₹7.62 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Apr 2026101296921Hdfc Bank Limited₹22.92 LakhOpen
24 Sep 2025101167608Hdfc Bank Limited₹11.46 LakhOpen
02 May 2025101097091Hdfc Bank Limited₹13.71 LakhOpen
24 Mar 2025101079046Others₹4.32 CrOpen
15 Sep 2023100820949Hdfc Bank Limited₹7.6 LakhOpen

To see the full charge records of Star Imaging and Path Lab Limited, buy the company report.

Total charge records: 28 View all charges

Deals & funding

Star Imaging and Path Lab Limited has 9 deals on record (3 secondary share transfers, 3 market trades, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in June 2026.

Total deals
9
Secondary share transfers
3
Market trades
3
Funding rounds
2
IPO
1
Disclosed funding
₹1.49 Cr

Deals on record (5 of 9)

WhenDealAmountParties
Jun 2026Market trade₹90.5 LakhBuyer: an individual
Sep 2025Market trade₹2.9 CrSeller: Strategic Sixth Sense Capital Fund
Aug 2025Market trade₹3.29 CrBuyer: Share India Securities Limited, Achintya Securities Limited
Seller: Share India Securities Limited
Aug 2025IPO₹69.47 CrInvestors: Mili Capital Investement, Compact Structure Fund, Persistent Growth Fund
Seller: an individual
Jul 2025Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

To see the full deal history of Star Imaging and Path Lab Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Star Imaging and Path Lab Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Star Imaging and Path Lab has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2

To see the full GST registrations and return filing status of Star Imaging and Path Lab Limited, buy the company report.

Recent activity

Star Imaging and Path Lab Limited has 19 board changes on record since 2004: 7 appointments and 12 cessations. The latest: Neelam Ratra ceased to be Additional Director on 24 Jun 2025.

Charges
A charge with Others of Rs. 4.80 Cr registered on 25 Sep 2021 with Charge ID 100521919 was modified on 25 Jun 2026.
Charges
A charge registered on 12 Feb 2025 via Charge ID 101049869 with Others was fully satisfied on 19 Jun 2026.
Charges
A charge registered on 15 Jan 2025 via Charge ID 101052185 with Axis Bank Limited was fully satisfied on 26 May 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101296921 was registered on 30 Apr 2026.
Filing
Star Imaging And Path Lab Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi Ii.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.11 Cr with Charge ID 101167608 was registered on 24 Sep 2025.
Charges
A charge registered on 31 Oct 2023 via Charge ID 100807768 with Others was fully satisfied on 02 Sep 2025.
Charges
A charge registered on 15 Jan 2025 via Charge ID 101052168 with Axis Bank Limited was fully satisfied on 29 Aug 2025.
Charges
A charge registered on 15 Jan 2025 via Charge ID 101052182 with Axis Bank Limited was fully satisfied on 29 Aug 2025.
AGM
Star Imaging And Path Lab Limited last Annual general meeting of members was held on 24 Jul 2025 as per latest MCA records.
Ceased
Neelam Ratra ceased to be Additional Director.
Appointed
Neelam Ratra was appointed as Director.

60 earlier events are in the company report.

Frequently asked questions

Star Imaging and Path Lab is an active public limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 31 May 2004 (22+ years old) and is registered under CIN L85110DL2004PLC126679. Listed on BSE: 544482.

Star Imaging and Path Lab reported revenue of ₹88.53 Cr for FY 2025-26 (up 6% YoY) based on consolidated financials.

Star Imaging and Path Lab has 7 current directors:

The latest financial statements of Star Imaging and Path Lab on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 24 July 2025. Year-wise statements from 2015 are in the company report.

No. Star Imaging and Path Lab has 2 GST registrations on record and all of them are cancelled or inactive.

The CIN (Corporate Identification Number) of Star Imaging and Path Lab is L85110DL2004PLC126679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Star Imaging and Path Lab is a listed company as per MCA records. Its shares are listed on BSE (code: 544482).

Star Imaging and Path Lab has 5 court cases on record: 4 filed by the company and 1 filed against it. 1 is pending.

Star Imaging and Path Lab was incorporated on 31 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.

Star Imaging and Path Lab has 9 deals on record (3 secondary share transfers, 3 market trades, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in June 2026.

The peers of Star Imaging and Path Lab by revenue are Atulaya Healthcare Private Limited, Pulse Diagnostics Private Limited, Sanghi Medical Centre Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).